Enlivex Therapeutics Ltd (ENLV)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current ENLV market cap is 24.22M. The company's latest EPS is USD -1.3921 and P/E is -0.85.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -5.63M | -6.09M | -3.95M | -2.99M | -3.12M |
| Net Income | -5.96M | -9.1M | -4.14M | -3.1M | -2.6M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -8.62M | -9.79M | -19.29M | -25.8M | -25.15M |
| Net Income | -9.38M | -11.82M | -14.47M | -31.06M | -29.07M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 46.94M | 36.83M | 31.05M | 31.9M | 29.8M |
| Total Liabilities | 8.16M | 6.75M | 4.2M | 3.34M | 3.21M |
| Total Equity | 38.78M | 30.08M | 26.85M | 28.56M | 26.59M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 17.56M | 40.36M | 95.15M | 67.64M | 36.83M |
| Total Liabilities | 6.28M | 4.87M | 10.11M | 10.8M | 6.75M |
| Total Equity | 11.28M | 35.49M | 85.04M | 56.84M | 30.08M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -18.25M | -23.52M | -4.51M | -6.31M | -8.92M |
| Investing | -30.1M | -25.97M | 5.1M | 4.3M | 5.7M |
| Financing | 360k | 360k | 524k | 4.94M | 5.19M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -7.04M | -11.01M | -17.54M | -23.95M | -23.52M |
| Investing | -6.36M | -20.98M | -38.41M | 62.52M | -25.97M |
| Financing | 8.31M | 33.08M | 60.98M | 150k | 360k |
| Market Cap | 24.22M |
| Price to Earnings Ratio | -0.85 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 30.33 |
| Price to Book Ratio | 0.82 |
| Dividend Yield | - |
| Shares Outstanding | 20.88M |
| Average Volume (1 week) | 57.05k |
| Average Volume (1 Month) | 90.32k |
| 52 Week Change | -56.55% |
| 52 Week High | 4.59 |
| 52 Week Low | 0.8101 |
| Spread (Intraday) | 0.02 (1.74%) |
| Company Name | Enlivex Therapeutics Ltd |
| Address |
14 einstein street ness ziona, center 7403618 |
| Website | https://www.enlivex.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
